Outcome of Board Meeting

Date: November 05, 2026 To, To, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Mumbai – 400001 Bandra (E), Mumbai – 400051 BSE Scrip Code: 545005 NSE Scrip Symbol: PARASHLTH Subject: Outcome of Board Meeting held on November 05, 2026, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/Madam, Pursuant to Regulation 30, 33 and other applicable provisions of the SEBI Listing Regulations, as amended, we wish to inform you that the Board of Directors of the Company in their meeting held today, i.e., Thursday, November 05, 2026, transacted the following businesses: Based on the recommendations of the Audit Committee, considered and approved the Unaudited (Standalone and Consolidated) Financial Results (“Financial Results”) of the Company for the quarter and half year ended September 30, 2026, along with the unmodified Limited Review Reports (“Limited Review Reports”) issued by M/s. Walker Chandiok & Co LLP, Chartered Accountants (Firm Registration No. 001076N/N500013), the Statutory Auditors of the Company. A copy of the Financial Results along with the Limited review Reports have been enclosed herewith. Based on the recommendations of the Nomination and Remuneration Committee, approved the continuation of Mr. Kabir Kishin Thakur (DIN: 08422362), Non- Executive Non- Independent Director of the Company under Regulation 17(1D) of the SEBI Listing Regulations, subject to the approval of the Shareholders of the Company. Further, he is not debarred from holding office of Director by virtue of any SEBI Order or any other authority. The details as required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed. The meeting commenced at 05:30 P.M. (IST) and concluded at 06:08 P.M. (IST). This disclosure will also be hosted on the Company’s website at https://www.parashospitals.com/investors. We request you to kindly take the same on record. Thanking you. For Paras Healthcare Limited Rahul Kumar Company Secretary and Compliance Officer ICSI Membership No.: A20928 Information as required under Regulation 30 – Para A of Part A of Schedule III to the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 – Continuation of directorship of Mr. Kabir Kishin Thakur (DIN: 08422362) as Non-Executive Non-Independent Director of the Company under Regulation 17(1D) of SEBI Listing Regulations Sl. No. Particulars Details 1 Reason for change viz. appointment, re- Continuation of directorship as a Non-Executive Non- appointment, resignation, removal, Independent Director death or otherwise (Continuation of Directorship) 2 Date of appointment/re- Based on the recommendations of the Nomination appointment/cessation (as applicable) & and Remuneration Committee of the Board, the Board term of appointment/re-appointment of Directors of the Company, at its meeting held on (Continuation of Directorship) November 05, 2026, approved the continuation of directorship of Mr. Kabir Kishin Thakur (DIN:08422362), as a Non-Executive Non- Independent Director of the Company under Regulation 17(1D) of SEBI Listing Regulations, liable to retire by rotation, which shall be effective from the date of passing of resolution by the Shareholders. 3 Brief profile (in case of appointment) Mr. Thakur has passed the final examinations for bachelor’s in commerce degree and Master of Management Studies degree, each from the University of Mumbai. He has over 19 years of experience in the field of investment and private equity. He was previously associated with ChrysCapital Group as a director. Prior to this role, he spent 2 years at Citibank’s investment banking division. Prior to this role, he spent 2 years at Citibank’s investment banking division. He is currently the designated partner of CR Advisors LLP and Creador Conscienta LLP. 4 Disclosure of relationships between He is not related to any of the Directors of the directors (in case of appointment of a Company. director)